Head-to-head · WeighScore
Nalena vs NuuVim
The verdict
Nalena takes it — 71.2/100 to 68.2/100.
Nalena grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Nalena is a women-focused, GLP-1-only telehealth platform offering compounded semaglutide and tirzepatide with medication included — no separate membership or visit fees.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Nalena | NuuVim |
|---|---|---|
| WeighScore | 71.2/100 | 68.2/100 |
| Grade | C | C |
| Scorecard rank | #97 | #153 |
| Semaglutide | $149/mo (starting dose, compounded) | $79/mo (all doses, 3-mo plan, new patients only, compounded) |
| Tirzepatide | $149/mo (starting dose, compounded) | $133/mo (all doses, 3-mo plan, new patients only, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #97 · C
Strengths
- Compounded GLP-1 from $149/mo with medication included — near the floor of the compounded market
- Transparent fee model: no hidden fees, no membership, cancel anytime
- Money-back guarantee — uncommon among compounded telehealths
- Clinical provider disclosed: Beluga Health, P.A. in Houston, TX
- Women-focused positioning
Where it loses points
- Per-dose pricing not published — only the 'starting at $149' entry price
- No LegitScript, HIPAA, or NABP badges on public pages
- Compounding pharmacy partners not named (only 'multiple USA certified pharmacies')
- Houston address looks like a virtual office rather than a clinical facility
- No brand-name GLP-1s (Wegovy, Zepbound, Ozempic, Mounjaro) — compounded only
Graded #153 · C
Strengths
- Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
- Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
- LegitScript Certified and HIPAA-compliant
- Two named compounding pharmacy partners (Hallandale Pharmacy and Pharmacy Hub), both vetted in our directory
- Operating legal entity disclosed: NuuVim LLC, Texas governing law
Where it loses points
- There is no month-to-month plan: every rate is billed as one three-month payment
- The advertised $79 and $133 are introductory rates for customers new to GLP-1s; on renewal they become $133 and $199.67
- The site's own llms.txt advertises pricing, FAQ and terms files that all 404
- No state count is published
- FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.